Adolescents and Young Adults (AYA) with Myeloproliferative Neoplasms (MPNs): Analysis of Patient Outcomes and Impact of High-Molecular Risk Mutations
Sign Up to like & getrecommendations! Published in 2024 at "Blood"
DOI: 10.1182/blood-2024-202606
Abstract: Introduction: Despite the median age of classical MPN being 65 years (yrs) old, an increasingly recognized group is comprised of AYA patients (pts) aged 15-39 yrs. The impact of high-molecular risk mutations (HMR) have begun… read more here.
Keywords: non aya; risk; aya non; aya ... See more keywords